The Indian Journal of Pediatrics

, Volume 85, Issue 11, pp 978–983 | Cite as

Quality of Life (QoL) and the Factors Affecting it in Transfusion-dependent Thalassemic Children

  • Kapil Chordiya
  • Vikash KatewaEmail author
  • Pramod Sharma
  • Bindu Deopa
  • Suman Katewa
Original Article



To evaluate the Quality of life (QoL) and the factors affecting it in transfusion-dependent thalassemic children.


Current study was conducted at Department of Pediatrics, Dr. SNMC, Jodhpur. Ninety-three transfusion-dependent thalassemic children aged between 8 and 18 y were enrolled. Quality of life was assessed using Pediatric Quality of Life (PedsQL) measurement model in thalassemic children.


Mean age of children was 11.8 ± 3.2 y. Lowest mean score was observed in School functioning (57.4) while in Physical functioning, Emotional functioning and Social functioning it was 73.9, 82.2 and 83.49 respectively. Mean PedsQL score was higher in 8-12 y age group as compared to 13-18 y (p = 0.024). PedsQL score was higher in children who required transfusion once in a month (p = 0.028) and children on combined chelation therapy as compared to children who were on injectable chelator (p = 0.039). Health Related QoL was not affected with gender, education status, family history of thalassemia, ferritin level, splenectomy or consanguinity.


Factors related with low QoL in current study were higher age, increased transfusion frequency and injectable mode of chelation. In order to improve the QoL in thalassemic children appropriate programmes and interventions should be started targeting above domains.


Thalassemia Transfusion-dependent PedsQL 



KC: Enrolled the patients and prepared the manuscript; VK: Designed the study and analysed and prepared the manuscript; PS: Designed, planned and analysed and prepared the manuscript; BD: Patient enrollment, data collection and analysis; SK: Data analysis, preparation of manuscript and reviewing the manuscript. PS will act as guarantor for this paper.

Compliance with Ethical Standards

Conflict of Interest



  1. 1.
    Kaheni S, Yaghobian M, Sharefzadah GH, Vahidi A, Ghorbani H, Abderahemi A. Quality of life in children with Β-thalassemia major at center for special diseases. Iran J Pediatr Hematol Oncol. 2013;3:108–13.Google Scholar
  2. 2.
    Colah RB, Gorakshakar AC, Nadkarni AH. Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India. Indian J Med Res. 2011;134:552–60.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Eiser C. Psychological effects of chronic disease. J Child Psychol Psychiatry. 1990;31:85–98.CrossRefGoogle Scholar
  4. 4.
    Esmaeilzadeh F, Azarkeivan A, Emamgholipour S, et al. Economic burden of thalassemia major in Iran, 2015. J Res Health Sci. 2016;16:111–5.PubMedGoogle Scholar
  5. 5.
    Ygge BM, Arnett JE. A study of parental involvement in pediatric hospital care: implications for clinical practice. J Paediatr Nurs. 2004;19:217–23.CrossRefGoogle Scholar
  6. 6.
    Varni JW, Seid M, Rode CA. The PedsQL™: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126–39.CrossRefGoogle Scholar
  7. 7.
    Soni S, Thawani R, Idhate T, Kalra M, Mahajan A. Health related quality of life in patients with transfusion- dependent thalassemia. Indian Pediatr. 2016;53:741–2.CrossRefGoogle Scholar
  8. 8.
    Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr. 2007;74:727–30.CrossRefGoogle Scholar
  9. 9.
    Gupta M, Jindal R. Quality of life in patients with thalassemia major. Int J Sci Res. 2016;5:41–2.Google Scholar
  10. 10.
    Sharma S, Seth B, Jawade P, Ingale M, Setia MS. Quality of life in children with thalassemia and their caregivers in India. Indian J Pediatr. 2017;84:188–94.CrossRefGoogle Scholar
  11. 11.
    Akbar Bagloo M, Habibpour Z. Relationship between mental health and use of agreeable methods in the parents with thalassemia and hemophilia. UNMF. 2010;8:191–6.Google Scholar
  12. 12.
    Gharaibeh HF, Gharaibeh MK. Factors influencing health-related quality of life of thalassaemic Jordanian children. Child Care Health Dev. 2012;38:211–8.CrossRefGoogle Scholar
  13. 13.
    Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health related quality of life in Malaysian children with thalassaemia. Health Qual Life Outcomes. 2006;4:39.CrossRefGoogle Scholar
  14. 14.
    Baraz S, Miladinia M, Nouri EM. A comparison of quality of life between adolescences with beta thalassemia major and their healthy peers. Int J Pediatr. 2016;4:1195–204.Google Scholar
  15. 15.
    Ayoub MD, Radi SA, Azab AM, Abulaban A, Balkhoyor AH, Bedair SW. Quality of life among children with beta-thalassemia major treated in western Saudi Arabia. Saudi Med J. 2013;34:1281–6.PubMedGoogle Scholar
  16. 16.
    Pakbaz Z, Treadwell M, Yamshita R, et al. Quality of life in patients with thalasssemia intermediate compared to thalassemia major. Ann N Y Acad Sci. 2005;1054:457–61.CrossRefGoogle Scholar
  17. 17.
    Riaz H, Riaz T, Khan MU, et al. Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan. BMC Res Notes. 2011;4:287.CrossRefGoogle Scholar
  18. 18.
    Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disord. 2010;10:1.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Khurana A, Katyal S, Marwaha RK. Psychosocial burden in thalaasemia. Indian J Pediatr. 2006;73:877–80.CrossRefGoogle Scholar
  20. 20.
    Cheuk DK, Mok AS, Lee AC. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant. 2008;42:319–27.CrossRefGoogle Scholar
  21. 21.
    Caocci G, Efficace F, Ciotti F, et al. Health related quality of life in middle eastern children with beta-thalassemia. BMC Hematol. 2012;12:6.CrossRefGoogle Scholar
  22. 22.
    Mikelli A, Tsiantis J. Brief report: depressive symptoms and quality of life in adolescents with b-thalassaemia. J Adolesc. 2004;27:213–6.CrossRefGoogle Scholar
  23. 23.
    Dahlui M, Hishamshah MI, Rahman AJA, Aljunid SM. Quality of life in transfusion dependent thalassaemia patients on desferrioxamine treatment. Singap Med J. 2009;50:794–9.Google Scholar
  24. 24.
    Naderi M, Hormozi MR, Ashrafi M, Emamdadi A. Evaluation of mental health and related factors among patients with beta-thalassemia major in south east of Iran. Iran J Psychiatry. 2012;7:47–51.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M. Quality of life in thalassemia. Ann N Y Acad Sci. 2005;1054:273–82.CrossRefGoogle Scholar
  26. 26.
    Cappellini MD, Cohen A, Piga A, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455–62.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  • Kapil Chordiya
    • 1
  • Vikash Katewa
    • 1
    Email author
  • Pramod Sharma
    • 1
  • Bindu Deopa
    • 2
  • Suman Katewa
    • 3
  1. 1.Department of PediatricsDr. S. N. Medical CollegeJodhpurIndia
  2. 2.Department of PediatricsPGIMER, Dr. RML HospitalNew DelhiIndia
  3. 3.Department of Obstetrics & GynaecologyDr. S. N. Medical CollegeJodhpurIndia

Personalised recommendations